SCHEMBL677340

SCHEMBL677340

COC=CC(C)=C(C#N)C#N

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL677339 1.00 KDM4E (0.33) KDM4EALDH1A1HTTRECQL
SCHEMBL6568350 0.76 CASP1 (0.41)
SCHEMBL6568347 0.76 CASP1 (0.41)
SCHEMBL19073216 0.72 TDP1 (0.32)
SCHEMBL11996575 0.68
SCHEMBL16550068 0.67 RAB9A (0.38)
SCHEMBL14139701 0.67
SCHEMBL28447302 0.65
SCHEMBL11005619 0.64
SCHEMBL12511131 0.62 TDP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105859614-B Method for preparing 2-chloro-3-cyano-4-methylpyridine 盐城迪赛诺制药有限公司 2020-05-26 CN claimed
EP-1326836-B1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE BOEHRINGER INGELHEIM CHEMICALS (US) 2004-05-06 EP claimed
EP-1326836-A1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE Boehringer Ingelheim Chemicals, Inc. (US) 2003-07-16 EP claimed
US-6399781-B1 A KEY INTERMEDIATE IN THE PRODUCTION OF NEVIRAPINE, STARTING BY REACTING ACETYLACETALDEHYDE DIMETHYL ACETAL WITH MALONONITRILE, IN THE PRESENCE OF AN AMMONIUM SALT CATALYST BOEHRINGER INGELHEIM CHEMICALS, INC. 2002-06-04 US claimed
US-20020052507-A1 Process for making 3-amino-2-chloro-4-methylpyridine BOEHRINGER INGELHEIM CHEMICALS, INC. 2002-05-02 US claimed
WO-2002030901-A1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE BOEHRINGER INGELHEIM CHEMICALS, INC. (US) 2002-04-18 WO claimed
CN-105859614-B Method for preparing 2-chloro-3-cyano-4-methylpyridine 盐城迪赛诺制药有限公司 2020-05-26 CN disclosed
US-20170188579-A1 FUNGICIDAL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASES ISHIHARA SANGYO KAISHA (JP) 2017-07-06 US disclosed
US-9655362-B2 Fungicidal composition and method for controlling plant diseases ISHIHARA SANGYO KAISHA, LTD. (JP) 2017-05-23 US disclosed
EP-1679003-B1 BACTERICIDE COMPOSITION AND METHOD OF CONTROLLING PLANT DISEASE ISHIHARA SANGYO KAISHA (JP) 2015-04-15 EP disclosed
US-8653113-B2 Fungicidal composition and method for controlling plant diseases ISHIHARA SANGYO KAISHA, LTD. (JP) 2014-02-18 US disclosed
US-8653277-B2 Fungicidal composition and method for controlling plant diseases ISHIHARA SANGYO KAISHA, LTD. (JP) 2014-02-18 US disclosed
US-8609150-B2 Fungicidal composition and method for controlling plant diseases ISHIHARA SANGYO KAISHA, LTD. (JP) 2013-12-17 US disclosed
EP-1326836-B1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE BOEHRINGER INGELHEIM CHEMICALS (US) 2004-05-06 EP disclosed
EP-1326836-A1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE Boehringer Ingelheim Chemicals, Inc. (US) 2003-07-16 EP disclosed
EP-1326836-A1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE Boehringer Ingelheim Chemicals, Inc. (US) 2003-07-16 EP disclosed
US-6399781-B1 A KEY INTERMEDIATE IN THE PRODUCTION OF NEVIRAPINE, STARTING BY REACTING ACETYLACETALDEHYDE DIMETHYL ACETAL WITH MALONONITRILE, IN THE PRESENCE OF AN AMMONIUM SALT CATALYST BOEHRINGER INGELHEIM CHEMICALS, INC. 2002-06-04 US disclosed
US-20020052507-A1 Process for making 3-amino-2-chloro-4-methylpyridine BOEHRINGER INGELHEIM CHEMICALS, INC. 2002-05-02 US disclosed
WO-2002030901-A1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE BOEHRINGER INGELHEIM CHEMICALS, INC. (US) 2002-04-18 WO disclosed
WO-2002030901-A1 PROCESS FOR MAKING 3-AMINO-2-CHLORO-4-METHYLPYRIDINE BOEHRINGER INGELHEIM CHEMICALS, INC. (US) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052507-A1 Process for making 3-amino-2-chloro-4-methylpyridine MTAP, TPMT, AMPD2 KDM4E 257/4885ALDH1A1 1260/4885HTT 1099/4885
US-20170188579-A1 FUNGICIDAL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASES CBR3, CNPY2, PAH KDM4E 1724/4885ALDH1A1 1250/4885HTT 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.